Company intelligence / Profile preview

PM Equity Partner

Lausanne, Vaud, Switzerland

Ownership: Private
Employees: ~25
Development stage: Other

Overview

PM Equity Partner is the corporate venture capital and private equity investment arm of Philip Morris International. It invests in technology-based business models across life sciences, wellness, healthcare, sustainability, and related sectors, with a focus on impactful and smoke-free innovations. The firm operates globally, leveraging PMI’s resources and research ecosystem.

Industry: Investors

Beyond the preview

Go deeper on PM Equity Partner.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PM Equity Partner.

Explore the full profile